Wordt geladen...
Selective targeting of glucagon-like peptide-1 signalling as a novel therapeutic approach for cardiovascular disease in diabetes
Glucagon-like peptide-1 (GLP-1) is an incretin hormone whose glucose-dependent insulinotropic actions have been harnessed as a novel therapy for glycaemic control in type 2 diabetes. Although it has been known for some time that the GLP-1 receptor is expressed in the CVS where it mediates important...
Bewaard in:
| Gepubliceerd in: | Br J Pharmacol |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BlackWell Publishing Ltd
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4301685/ https://ncbi.nlm.nih.gov/pubmed/25231355 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.12943 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|